Waters Corporation (WAT) Monthly Stock Report
Publication Date: September 22, 2024
Company Overview
Waters Corporation (WAT), based in Milford, Massachusetts, is a prominent player in the healthcare sector, specializing in diagnostics and research. Founded in 1958, the company has made a name for itself by offering advanced analytical workflow solutions, particularly in high-performance liquid chromatography and mass spectrometry technology systems. Waters operates through two main segments: Waters and TA, providing essential instruments for drug discovery, development, and quality assurance across various applications such as pharmaceuticals, environmental testing, and life sciences research. With a total revenue of approximately $2.88 billion, Waters Corporation stands as a solid investment choice in the Diagnostics & Research industry.
Performance Highlights
As of the latest assessment, the stock price of Waters Corporation is $336.56, comfortably positioned above the fifty-day moving average of $328.809, indicating a favorable short-term performance. The company anticipates a target high price of $380.00 and a target mean price of $341.30, suggesting a moderate growth potential. Investors should note that the stock has demonstrated significant volatility over the past year, with a 52-week high of $367.21 and a low of $231.90. Currently, there are 59,361,900 shares outstanding, of which approximately 5.4% (2,822,210 shares) are shorted, reflecting investor confidence in the company’s ongoing growth outlook.
Investment Insight
Given the market dynamics and analysis from 16 financial analysts, the consensus recommendation for Waters Corporation is to “hold” the stock, with a mean score of 2.9. The analysis indicates potential price appreciation in the range of $300.00 to $380.00, encouraging investors to maintain their existing positions while closely monitoring developments within the healthcare sector that could impact stock performance. However, it’s essential to note the absence of EBITDA data, which is crucial for evaluating profitability and financial stability, warranting further investigation. Investors should remain vigilant as they navigate the company’s growth trajectory amidst fluctuating market conditions.
| Metric | Value |
|---|---|
| Market Cap | $20.0b |
| Total Debt | $2.1b |
| Total Cash | $327.4m |
| Shares Outstanding | 59.4m |
| Float Shares | 59.2m |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.